Sit Investment Associates Inc. Raises Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Sit Investment Associates Inc. grew its position in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 104.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,600 shares of the company's stock after buying an additional 11,050 shares during the quarter. Sit Investment Associates Inc. owned 0.08% of Establishment Labs worth $995,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. R Squared Ltd purchased a new stake in Establishment Labs in the 4th quarter valued at approximately $36,000. KLP Kapitalforvaltning AS purchased a new stake in shares of Establishment Labs in the fourth quarter valued at $161,000. Handelsbanken Fonder AB lifted its position in shares of Establishment Labs by 32.3% in the fourth quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock valued at $378,000 after acquiring an additional 2,000 shares in the last quarter. Verition Fund Management LLC boosted its stake in shares of Establishment Labs by 22.8% during the third quarter. Verition Fund Management LLC now owns 9,400 shares of the company's stock valued at $407,000 after acquiring an additional 1,746 shares during the last quarter. Finally, HighTower Advisors LLC increased its position in Establishment Labs by 32.5% during the 3rd quarter. HighTower Advisors LLC now owns 10,311 shares of the company's stock worth $446,000 after purchasing an additional 2,529 shares in the last quarter. 72.91% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Stephens restated an "overweight" rating and issued a $52.00 target price on shares of Establishment Labs in a report on Thursday, March 6th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, Establishment Labs presently has a consensus rating of "Moderate Buy" and a consensus price target of $57.40.

Establishment Labs Trading Up 0.7 %

Shares of ESTA stock traded up $0.20 during mid-day trading on Friday, hitting $30.34. 720,554 shares of the company's stock were exchanged, compared to its average volume of 448,083. The stock has a market cap of $875.19 million, a price-to-earnings ratio of -11.76 and a beta of 0.77. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. Establishment Labs Holdings Inc. has a fifty-two week low of $26.56 and a fifty-two week high of $60.12. The stock has a 50-day simple moving average of $36.44 and a two-hundred day simple moving average of $40.11.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.34). Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The business had revenue of $44.51 million during the quarter, compared to analyst estimates of $44.45 million. Equities analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.